As of May 31, 2025, Neogen Corp (NEOG) reports a EV/EBITDA of -6.55.
EV/EBITDA evaluates a company's total value relative to its earnings before interest, taxes, depreciation, and amortization, useful for comparing firms with different capital structures.
Comparing Neogen Corp's EV/EBITDA to Peers
To better understand Neogen Corp's position, it's useful to compare its EV/EBITDA against industry peers. Below are selected comparisons:
Company | EV/EBITDA |
---|---|
Neogen Corp (NEOG) | -6.55 |
BioLife Solutions Inc (BLFS) | 177.85 |
Atrion Corp (ATRI) | 26.39 |
Merit Medical Systems Inc (MMSI) | 21.06 |
Meridian Bioscience Inc (VIVO) | 17.49 |
ICU Medical Inc (ICUI) | 15.92 |
Compared to its competitors, Neogen Corp's EV/EBITDA is about average compared to peers, indicating market valuation in line with industry expectations.